Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

BACKGROUND: Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Everson, Richard G., Antonios, Joseph P., Lisiero, Dominique N., Soto, Horacio, Scharnweber, Rudi, Garrett, Matthew C., Yong, William H., Li, Ning, Li, Gang, Kruse, Carol A., Liau, Linda M., Prins, Robert M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2016
Schlagworte:
Basic and Translational Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767237/
https://ncbi.nlm.nih.gov/pubmed/26330563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov153
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge